April 15, 2026

Diabetic Retinal Disease Rates Narrow by Diabetes Type

US claims data showed rising prevalence of diabetic retinal disease in type 1 and type 2 diabetes, while incidence declined in type 1 diabetes and moved closer to type 2 rates by 2022.

Conexiant

April 13, 2026

AI Falls Short on Differential Dx

New PrIME-LLM benchmark shows strong diagnostic accuracy but persistent gaps in clinical reasoning across 21 large language models

Conexiant

April 13, 2026

Utah Just Let an Algorithm Write Prescriptions

Physician oversight waived in state sandbox; federal review status unclear

Conexiant

April 10, 2026

Where Oversight, Compliance, and Risk Intersect

Cases spanning fraud, regulation, and criminal law illustrate how gaps and uncertainty can influence outcomes in healthcare settings

Conexiant

April 10, 2026

Influenza Vaccine Dose and Dementia Outcomes

US claims data compare high- vs standard-dose formulations in patients aged 65 years or more over 3 years of follow-up

Conexiant

April 09, 2026

Matrix Stiffness Regulates Gingival Immunity

3D hydrogel and explant models link tissue mechanics to fibroblast signaling and immune cell differentiation.

Conexiant

April 09, 2026

Long COVID May Raise Cardiovascular Risk

Population-based cohort shows higher rates of cardiac arrhythmias and coronary artery disease following nonhospitalized infections, with sex-specific differences.

Conexiant

April 09, 2026

Medical Oddities: Tattoos and Teeth Share Work Struggles

From unexpected workplace parallels to kitchen-counter experiments and a few clinical twists, this set of stories covered more ground than your average shift.

Conexiant

April 09, 2026

Medications May Affect Fracture Healing

Evidence varies by drug class, with limited data on union outcomes

Conexiant

April 09, 2026

GLP-1 Analysis: Riding the Wave of Peptide Innovation

The remarkable commercial success of GLP-1 receptor agonists is fueling investment, accelerating science, and creating new analytical challenges. Here, we outline the hurdles these peptides present, explore methods for impurity profiling and structural characterization, and consider strategies to keep pace with this fast-moving field.

The Medicine Maker